Eisai and Biogen Showcase Promising Long-Term Data for Lecanemab in Early Alzheimer’s Disease at CTAD 2023

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 01, 2024 | Friday | News
Bristol Myers Squibb to Present New Data on COBENFY™ for Schizophrenia at Psych Congress 2024

Bristol Myers Squibb (NYSE: BMY) announced that new clinical and health economics and outcomes research data (HEOR) from its neuropsychiatry portfolio...

October 29, 2024 | Tuesday | News
Novartis Unveils Promising 12-Month Data for Fabhalta® in C3 Glomerulopathy at ASN Kidney Week 2024

Novartis presented 12-month data from the Phase III APPEAR-C3G study at American Society of Nephrology (ASN) Kidney Week 2024 showing that patients with C3...

October 28, 2024 | Monday | News
Exact Sciences to Present Innovative CRC Screening Data at ACG Annual Meeting

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced the company will present modeling data evaluati...

October 28, 2024 | Monday | News
Gilead Sciences to Present Pivotal Research at The Liver Meeting® 2024

Gilead Sciences, Inc. (Nasdaq: GILD) announced new research to be presented at The Liver Meeting ® 2024, hosted by the American Association f...

October 23, 2024 | Wednesday | News
Sutro Biopharma Showcases Proprietary Cell-Free Platform for Next-Generation ADC Development

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company pioneering the development of site-specific and novel-format antibody-drug conjug...

October 11, 2024 | Friday | News
Global TB Summit 2024: QIAGEN’s QuantiFERON®-TB Gold Plus Blood Test at the Forefront of Latent TB Detection and Global Disease Control

QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in ...

October 08, 2024 | Tuesday | News
Enzene Launches Advanced EnzeneX™ 2.0 Platform at CPHI Milan

Enzene, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced it is to launch its new EnzeneX&trad...

October 07, 2024 | Monday | News
Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
Dräger Honored with 2024 AARC Zenith Award for Excellence in Respiratory Care Support

Award criteria include quality of equipment, service and customer support The American Association for Respiratory Care (AARC) selected Dräger for ...

September 25, 2024 | Wednesday | News
Oxford-Harrington Rare Disease Centre Kicks Off Bi-Annual Symposium at University of Oxford

The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at U...

September 24, 2024 | Tuesday | News
ESMO 2024 Congress: Breakthroughs in Cancer Treatment and Key Approvals

The European Society for Medical Oncology (ESMO) 2024 Congress, held from September 13 to 17 in Barcelona, brought together global oncology experts to un...

September 23, 2024 | Monday | News
Immutep Presents Promising Phase IIb Trial Results of Efti and KEYTRUDA® at ESMO 2024

Results delivered in prestigious Proffered Paper oral presentation at ESMO Congress 2024 In patients with any PD-L1 expression (CPS ≥1), efti in co...

September 17, 2024 | Tuesday | News
Rapid Micro Biosystems to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), a pioneering life sciences technology firm that offers critical automation solut...

September 04, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close